DNA methylation: A promising landscape for immune system-related diseases

Trends in Genetics

Volumn 28, Issue 10, 2012, Pages 506-514

  Suarez Alvarez, Beatriz ^a   Rodriguez, Ramon M ^b   Fraga, Mario F ^b   López Larrea, Carlos ^a,c  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c Section of Nephrology   (Spain)

Author keywords

Autoimmunity; DNA methylation; DNMTs; Hematopoiesis; Plasticity

Indexed keywords

CD19 ANTIGEN; CD40 LIGAND; CD70 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR2; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; EOMESODERMIN; FAS LIGAND; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INTEGRIN; INTERLEUKIN 4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; PERFORIN; PROGRAMMED DEATH 1 RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR T BET;

CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FATE; CELLULAR IMMUNITY; CHROMATIN STRUCTURE; CPG ISLAND; DEMETHYLATION; DENDRITIC CELL; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE INACTIVATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTONE MODIFICATION; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE FUNCTION TEST; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MISSENSE MUTATION; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; DNA METHYLATION; DNA MODIFICATION METHYLASES; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE SYSTEM DISEASES;

EID: 84866406017     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2012.06.005     Document Type: Review

References (99)

1. Okano M., et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
2. Li E., et al. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
3. Ehrlich M., et al. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet. J. Rare Dis. 2006, 1:2.
4. Kim M., et al. Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells. Nucleic Acids Res. 2004, 32:5742-5749.
5. Sen G.L., et al. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 2010, 463:563-567.
6. Trowbridge J.J., et al. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 2009, 5:442-449.
7. Broske A.M., et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat. Genet. 2009, 41:1207-1215.
8. Tadokoro Y., et al. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J. Exp. Med. 2007, 204:715-722.
9. Challen G.A., et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 2011, 44:23-31.
10. Calvanese V., et al. A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res. 2011, 40:116-131.
11. Ji H., et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 2010, 467:338-342.
12. Deaton A.M., et al. Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res. 2011, 21:1074-1086.
13. Bocker M.T., et al. Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood 2011, 117:182-189.
14. Borgel J., et al. Targets and dynamics of promoter DNA methylation during early mouse development. Nat. Genet. 2010, 42:1093-1100.
15. Shearstone J.R., et al. Global DNA demethylation during mouse erythropoiesis in vivo. Science 2011, 334:799-802.
16. Balasubramani A., et al. Modular utilization of distal cis-regulatory elements controls Ifng gene expression in T cells activated by distinct stimuli. Immunity 2010, 33:35-47.
17. Wilson C.B. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 2009, 9:91-105. Review.
18. Wei G. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
19. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11:674-680.
20. Lu K.T., et al. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity 2011, 35:622-632.
21. Thomas R.M., et al. De novo DNA methylation is required to restrict T helper lineage plasticity. J. Biol. Chem. 2012, 287:22900-22909.
22. Aune T.M., et al. Epigenetics and T helper 1 differentiation. Immunology 2009, 126:299-305.
23. Santangelo S., et al. DNA methylation changes at human Th2 cytokine genes coincide with DNase I hypersensitive site formation during CD4(+) T cell differentiation. J. Immunol. 2002, 169:1893-1903.
24. Schoenborn J.R., et al. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat. Immunol. 2007, 8:732-742.
25. Santangelo S., et al. Chromatin structure and DNA methylation of the IL-4 gene in human T(H)2 cells. Chromosome Res. 2009, 17:485-496.
26. Janson P.C., et al. Profiling of CD4+ T cells with epigenetic immune lineage analysis. J. Immunol. 2011, 186:92-102.
27. Mukasa R., et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010, 32:616-627.
28. Bending D., et al. Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J. Immunol. 2011, 186:3373-3382.
29. Cohen C.J., et al. Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J. Immunol. 2011, 187:5615-5626.
30. Ye J., et al. Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function. Eur. J. Immunol. 2011, 41:936-951.
31. Floess S., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007, 5:e38.
32. Baron U., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 2007, 37:2378-2389.
33. Lal G., et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 2009, 182:259-273.
34. Janson P.C., et al. FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 2008, 3:e1612.
35. Schmidl C., et al. Epigenetic reprogramming of the RORC locus during in vitro expansion is a distinctive feature of human memory but not naïve Treg. Eur. J. Immunol. 2011, 41:1491-1498.
36. Zhao M., et al. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J. Autoimmun. 2010, 35:58-69.
37. Lu Q., et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 2007, 179:6352-6358.
38. Sawalha A.H., et al. Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. J. Autoimmun. 2012, 38:J216-J222.
39. Steinfelder S., et al. Epigenetic modification of the human CCR6 gene is associated with stable CCR6 expression in T cells. Blood 2011, 117:2839-2846.
40. Ballestar E. Epigenetic alterations in autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 2011, 7:263-271.
41. Liu Y., et al. Decreased DNA methyltransferase levels contribute to abnormal gene expression in 'senescent' CD4(+)CD28(-) T cells. Clin. Immunol. 2009, 132:257-265.
42. Chen Y., et al. Decreased ERK and JNK signaling contribute to gene overexpression in 'senescent' CD4+ T cells through epigenetic mechanisms. J. Leukoc. Biol. 2010, 87:137-145.
43. Kersh E.N., et al. Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J. Immunol. 2006, 176:4083-4093.
44. Araki Y., et al. Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). J. Immunol. 2008, 180:8102-8108.
45. Thomas R.M., et al. Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J. Immunol. 2005, 174:4639-4646.
46. Zediak V.P., et al. The contribution of epigenetic memory to immunologic memory. Curr. Opin. Genet. Dev. 2011, 21:154-159.
47. Akbar A.N., Henson S.M. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?. Nat. Rev. Immunol. 2011, 11:289-295.
48. Blackburn S.D., et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 2009, 10:29-37.
49. Jones R.B., et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 2008, 205:2763-2779.
50. Youngblood B., et al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity 2011, 35:400-412.
51. Lanier L.L. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008, 9:495-502.
52. Thielens A., et al. NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr. Opin. Immunol. 2012, 24:239-245.
53. Chan H.W., et al. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 2003, 197:245-255.
54. Gómez-Lozano N., et al. Epigenetic silencing of potentially functional KIR2DL5 alleles: implications for the acquisition of KIR repertoires by NK cells. Eur. J. Immunol. 2007, 37:1954-1965.
55. Santourlidis S., et al. Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells. J. Immunol. 2008, 180:418-425.
56. Gao X.N., et al. Demethylating treatment suppresses natural killer cell cytolytic activity. Mol. Immunol. 2009, 46:2064-2070.
57. Li G., et al. Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells. J. Leukoc. Biol. 2008, 84:824-834.
58. Li G., et al. Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood 2009, 114:3422-3430.
59. Rogers S.L., et al. A role for DNA hypomethylation and histone acetylation in maintaining allele-specific expression of mouse NKG2A in developing and mature NK cells. J. Immunol. 2006, 177:414-421.
60. Ramírez J., et al. From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment. Curr. Opin. Immunol. 2010, 22:177-184.
61. Santos P., et al. Transcriptional and epigenetic regulation of B cell development. Immunol. Res. 2011, 50:105-112.
62. Lin Y.C., et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat. Immunol. 2010, 11:635-643.
63. Xu C.R., Feeney A.J. The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling. J. Immunol. 2009, 182:1362-1369.
64. Danbara M., et al. DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines. Mol. Immunol. 2002, 38:1161-1166.
65. Amaravadi L., Klemsz M.J. DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol. 1999, 18:875-884.
66. Maier H., et al. Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol. Cell. Biol. 2003, 23:1946-1960.
67. Cobaleda C., et al. Pax5: the guardian of B cell identity and function. Nat. Immunol. 2007, 8:463-470.
68. Decker T., et al. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Immunity 2009, 30:508-520.
69. Gao H., et al. Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:11258-11263.
70. Walter K., et al. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus. Blood 2008, 112:1673-1682.
71. Shaknovich R., et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 2011, 118:3559-3569.
72. Schwab J., Illges H. Regulation of CD21 expression by DNA methylation and histone deacetylation. Int. Immunol. 2001, 13:705-710.
73. Majumder P., Boss J.M. DNA methylation dysregulates and silences the HLA-DQ locus by altering chromatin architecture. Genes Immun. 2011, 12:291-299.
74. Seguín-Estévez Q., et al. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation. J. Immunol. 2009, 183:2545-2553.
75. Suarez-Alvarez B., et al. Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS ONE 2010, 5:e10192.
76. Garaud S. DNA methylation and B-cell autoreactivity. Adv. Exp. Med. Biol. 2011, 711:50-60.
77. Garaud S., et al. Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes. J. Immunol. 2008, 181:2010-2018.
78. Wessels I., et al. Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis. Immunology 2010, 130:410-417.
79. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
80. Takeuch O., Akira S. Epigenetic control of macrophage polarization. Eur. J. Immunol. 2011, 41:2490-2493.
81. Kim S.Y., et al. Methylome of fetal and maternal monocytes and macrophages at the feto-maternal interface. Am. J. Reprod. Immunol. 2012, 68:8-27.
82. Bullwinkel J., et al. Epigenotype switching at the CD14 and CD209 genes during differentiation of human monocytes to dendritic cells. Epigenetics 2011, 6:45-51.
83. Frikeche J., et al. Impact of the hypomethylating agent 5-azacytidine on dendritic cells function. Exp. Hematol. 2011, 39:1056-1063.
84. Mikkelsen T.S., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
85. Meissner A., et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008, 454:766-770.
86. Howlett S.K., Reik W. Methylation levels of maternal and paternal genomes during preimplantation development. Development 1991, 113:119-127.
87. Monk M., et al. Decrease in DNA methylase activity during preimplantation development in the mouse. Development 1991, 112:189-192.
88. Mayer W., et al. Demethylation of the zygotic paternal genome. Nature 2000, 403:501-502.
89. Niehrs C. Active DNA demethylation and DNA repair. Differentiation 2009, 77:1-11.
90. Bruniquel D., Schwartz R.H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 2003, 4:235-240.
91. Ko M., et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843.
92. He Y.F., et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307.
93. Sánchez-Abarca L.I., et al. Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting. Blood 2010, 115:107-121.
94. Choi J., et al. In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. Blood 2010, 116:129-139.
95. Goodyear O.C., et al. Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood 2012, 119:3361-3369.
96. Garcia-Manero G., Fenaux P. Hypomethylating agents and other novel strategies in myelodysplastic syndromes. J. Clin. Oncol. 2011, 29:516-523.
97. Fraga M.F., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10604-10609.
98. Fraga M.F., Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet. 2007, 23:413-418.
99. Berdasco M., Esteller M. Hot topics in epigenetic mechanisms of aging: 2011. Aging Cell 2011, 11:181-186.